v3.26.1
Disclosures on financial instruments Capital risk management (Tables)
12 Months Ended
Dec. 31, 2025
Veraxa Biotech A G [Member]  
Entity Information [Line Items]  
Schedule of financial instruments
           
    December 31,
2025
    December 31,
2024
 
Financial assets                
Cash and cash equivalents   1,613,989     5,362,638  
Financial assets measured at amortized cost   1,270,594     243,688